As of 2025-11-05, the EV/EBITDA ratio of Maravai LifeSciences Holdings Inc (MRVI) is -20.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRVI's latest enterprise value is 788.38 mil USD. MRVI's TTM EBITDA according to its financial statements is -39.40 mil USD. Dividing these 2 quantities gives us the above MRVI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 14.8x | 14.1x |
| Forward P/E multiples | 17.2x - 25.1x | 19.8x |
| Fair Price | (2.87) - (2.50) | (2.83) |
| Upside | -199.9% - -187.0% | -198.7% |
| Date | EV/EBITDA |
| 2025-11-04 | -20.01 |
| 2025-11-03 | -20.46 |
| 2025-10-31 | -21.76 |
| 2025-10-30 | -21.76 |
| 2025-10-29 | -21.30 |
| 2025-10-28 | -22.34 |
| 2025-10-27 | -23.05 |
| 2025-10-24 | -23.51 |
| 2025-10-23 | -23.96 |
| 2025-10-22 | -23.51 |
| 2025-10-21 | -23.25 |
| 2025-10-20 | -24.22 |
| 2025-10-17 | -22.79 |
| 2025-10-16 | -24.03 |
| 2025-10-15 | -23.25 |
| 2025-10-14 | -22.34 |
| 2025-10-13 | -22.79 |
| 2025-10-10 | -22.08 |
| 2025-10-09 | -22.79 |
| 2025-10-08 | -22.99 |
| 2025-10-07 | -22.86 |
| 2025-10-06 | -21.63 |
| 2025-10-03 | -21.43 |
| 2025-10-02 | -20.66 |
| 2025-10-01 | -21.76 |
| 2025-09-30 | -20.01 |
| 2025-09-29 | -19.75 |
| 2025-09-26 | -19.68 |
| 2025-09-25 | -18.84 |
| 2025-09-24 | -19.04 |
| 2025-09-23 | -19.17 |
| 2025-09-22 | -19.23 |
| 2025-09-19 | -18.91 |
| 2025-09-18 | -20.07 |
| 2025-09-17 | -19.62 |
| 2025-09-16 | -20.14 |
| 2025-09-15 | -19.04 |
| 2025-09-12 | -18.71 |
| 2025-09-11 | -19.49 |
| 2025-09-10 | -18.26 |
| 2025-09-09 | -18.65 |
| 2025-09-08 | -17.22 |
| 2025-09-05 | -17.67 |
| 2025-09-04 | -16.70 |
| 2025-09-03 | -16.70 |
| 2025-09-02 | -16.77 |
| 2025-08-29 | -17.09 |
| 2025-08-28 | -16.83 |
| 2025-08-27 | -16.51 |
| 2025-08-26 | -17.09 |